FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称MOLIBRESIB
异名/同义词(4S)-6-(4-CHLOROPHENYL)-N-ETHYL-8-METHOXY-1-METHYL-4H-(1,2,4)TRIAZOLO(4,3-A)(1,4)BENZODIAZEPINE-4-ACETAMIDE
2-((4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4HBENZO(F)(1,2,4)TRIAZOLO(4,3-A)(1,4)DIAZEPIN-4-YL)-N-ETHYLACETAMIDE
4H-(1,2,4)TRIAZOLO(4,3-A)(1,4)BENZODIAZEPINE-4-ACETAMIDE, 6-(4-CHLOROPHENYL)-N-ETHYL-8-METHOXY-1-METHYL-, (4S)-
BET INHIBITOR GSK525762
GSK525762
GSK-525762
GSK525762A
GSK-525762A
I-BET 762
MOLIBRESIB
MOLIBRESIB [INN]
MOLIBRESIB [USAN]
MOLIBRESIB [WHO-DD]
CAS登记号1260907-17-2
物质唯一标识(Unique Ingredient Identifier)5QIO6SRZ2R
分子式C22H22ClN5O2
国际化合物标识(International Chemical Identifier,InChI)AAAQFGUYHFJNHI-SFHVURJKSA-N
SMILESC(C[C@H]1c2n(c(nn2)C)-c3c(cc(cc3)OC)C(=N1)c4ccc(cc4)Cl)(=O)NCC
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System